Chronic hyperphosphatemia and hypocalcemia contribute to bone changes in CKD due to what mechanism?

• A. Elevated phosphate and low calcium stimulate parathyroid hormone leading to bone remodeling
• B. Hypercalcemia directly strengthens bone
• C. Calcium phosphate deposition without hormonal effects
• D. Vitamin D excess drives bone calcification

Answer: (A)

In CKD, mineral imbalance drives bone changes mainly through secondary hyperparathyroidism. The kidneys’ failure to excrete phosphate leads to high phosphate levels, and phosphate binds calcium, causing low serum calcium. At the same time, reduced activation of vitamin D by the diseased kidney lowers calcium absorption from the gut, worsening hypocalcemia. The low calcium and high phosphate stimulate the parathyroid glands to release more parathyroid hormone. This hormone increases bone turnover and resorption to liberate calcium (and phosphate) into the bloodstream, so bones undergo remodeling and the patient develops renal osteodystrophy. So the essential mechanism is PTH-driven bone remodeling triggered by the combination of hyperphosphatemia and hypocalcemia.